通过Citrullus lanatus对PDX1基因表达和血糖控制进行调节,用于2型糖尿病的实验
Anthony G S Moore1,2, Stanley I R Okoduwa3,4
1Department of Biochemistry, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Nigeria.
Scientific reports
|January 6, 2026
概括
(Citrullus lanatus) (非洲西瓜) 汁在糖尿病大鼠中改善了血糖控制和抗氧化剂状态. 果汁调节了胰腺和十二指肠本质盒1 (PDX1) 基因表达的表达,这表明它在治疗2型糖尿病方面发挥了作用.
科学领域:
- 内分泌学和新陈代谢学
- 营养科学 营养科学
- 分子生物学分子生物学
背景情况:
- 糖尿病是一种重大的全球健康挑战,其特点是高血糖和胰腺β细胞功能障碍.
- 目前的糖尿病治疗方法需要更安全,更有效的替代方案.
- (Citrullus lanatus) (非洲西瓜) 含有具有潜在抗高血糖和抗氧化特性的生物活性化合物.
研究的目的:
- 为了研究Citrullus lanatus果汁对糖尿病大鼠的血糖控制的影响.
- 为了检查C. lanatus果汁对胰腺和十二指肠本体盒1 (PDX1) 基因表达的影响.
- 在2型糖尿病模型中评估C. lanatus汁的抗氧化作用.
主要方法:
- 胰岛素诱导的糖尿病Wistar大鼠用不同剂量的C. lanatus果汁或甲福林治疗.
- 测量了血糖,胰岛素,C-和HDL水平.
- 胰腺组织分析了抗氧化酶活性,甲基水平和PDX1 mRNA表达.
主要成果:
- C. lanatus 果汁表现出快食血糖水平的剂量依赖性降低.
- 用C. lanatus果汁治疗显著增加了抗氧化酶的活性,并降低了甲水平.
- 在接受C. lanatus汁治疗的老鼠中,PDX1基因表达明显上调,与改善的血糖控制和胰岛素水平相关.
结论:
- 在老鼠模型中,Citrullus lanatus果汁表现出显著的抗糖尿病作用.
- 观察到的好处与增强PDX1基因表达,改善血糖控制和减少氧化应激有关.
- 拉纳图斯果汁显示出作为一种功能性饮食干预措施来管理2型糖尿病的潜力.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Dipeptidyl Peptidase 4 Inhibitors
575
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
575
Glucagon-like Receptor Agonists
836
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
836
Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K


